Midi as Womens Health Data Platform
Midi Health
These tools matter because they can turn Midi from a telehealth clinic into the system that captures, structures, and sells high intent women’s health knowledge. Inside the visit, AI cuts charting time and helps clinicians make faster decisions. Outside the visit, a women’s health search layer can collect rare symptom patterns, treatment questions, and care pathways that payers, employers, pharma, and digital health partners may eventually license as workflow software or aggregated insight products.
-
The clearest near term payoff is labor efficiency. Midi already runs on athenahealth and uses Ambience for AI scribing, with measured savings of more than 3 hours per provider per day. In a visit heavy model with frequent follow ups, that directly raises clinician capacity without opening clinics or hiring at the same rate.
-
The search engine idea points to a second business. Medical search products like OpenEvidence show that clinical Q and A tools can become monetizable infrastructure through enterprise features, workflow modules, and integration licensing. For Midi, the wedge is narrower but more differentiated, menopause, hormones, aging, and weight related care for women over 40.
-
Comparable women’s health platforms mostly monetize care delivery or employer benefits. Maven sells a broad employer telehealth benefit across fertility, maternity, pediatrics, and menopause, and reached an estimated $268M revenue in 2024. Midi’s software investments suggest a different angle, owning the decision layer and data exhaust from specialized care, not just the visit itself.
The likely next step is a stack where Midi handles the visit, the prescription, the supplement bundle, and the clinical reasoning software behind each interaction. If that works, revenue shifts from mostly reimbursed care toward a mix of care margins, software licensing, and data products, which would make Midi harder to copy than a standard virtual clinic.